NIGMS to Fund Network of PGx, Genomics-based Drug Prediction Science Centers | GenomeWeb

NEW YORK (GenomeWeb News) – The National Institutes of Health plans to fund a network of centers that will use pharmacogenomics and more advanced genomic approaches to develop innovative methods for predicting drug responses.

The National Institute for General Medical Sciences will provide up to $1.8 million per year to each of these research centers, which beginning in 2015 will serve as anchors for the Pharmacogenomics Research Network, a program NIH has supported since 2000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: experts say race is not a sufficient proxy for studying human genetic diversity and more.

Technology Review writes that CRISPR/Cas9 gene editing firm Editas' success may hinge on a patent case.

Researchers unearthed a bioinformatics error in the Science paper reporting the first ancient African genome, and the authors are seeking an erratum.

A boy's cystic fibrosis carrier status was revealed by a teacher to the parents of children with CF who then sought the boy's transfer to another school, leading to a lawsuit.

Sponsored by
Agilent Technologies

This webinar will discuss the use of a hybrid capture-based FFPE DNA sequencing methodology with the potential for advancing precision oncology studies.